Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Examining the Effectiveness of Multidisciplinary Care Teams in Improving Outcomes for Breast Cancer Patients [NA]
Completed clinical trial evaluating the effectiveness of multidisciplinary care teams in improving outcomes for patients with breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: The Effect of Breathing Exercise on Sleep and Stress Levels in Women With Breast Cancer Receiving Chemotherapy Treatment [NA]
This document indicates the completion of a clinical trial evaluating the effect of a breathing exercise on sleep quality and stress in wome…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study [Phase 2]
Phase 2 results from the Adaptive Nutrition and Exercise Weight Loss (A-NEW) study in overweight breast cancer patients were posted, detaili…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
A completed multicancer registry study (PREFER) assessing the prevalence of actionable biomarkers and driver mutations across advanced cance…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Radiation Therapy During Surgery in Treating Older Women With Stage I Breast Cancer [NA]
This document reports the completion of a clinical trial evaluating radiation therapy administered during surgery for older women with stage…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer [Phase 2]
This entry reports results from the CLEVER Pilot Trial, a Phase II study evaluating hydroxychloroquine, everolimus, or their combination to …
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Comparison of Full-Field Digital Mammography With Digital Breast Tomography for Screening Call-Back Rates [NA]
The trial compares full-field digital mammography with digital breast tomosynthesis to evaluate screening call-back rates.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Genetic Testing for All Breast Cancer Patients (GET FACTS) [NA]
The GET FACTS trial evaluates genetic testing for all breast cancer patients, with the study currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: LOL: It's All Improv After Cancer!™ [NA]
The study sponsored by Arash Asher, MD is reported as completed. It concerns breast cancer and psychological distress.
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Efficacy and Safety of Biweekly Regimen of Eribulin Versus a Standard Regimen for the Treatment of Locally Recurrent or Metastatic HER2-negative Breast Cancer: a Multicenter, Randomized, Open-label, Phase III Trial [Phase 3]
This Phase III trial update evaluates a biweekly regimen of eribulin versus a standard regimen for locally recurrent or metastatic HER2-nega…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer. [NA]
Clinical trial update describes evaluating Disitamab Vedotin with metronomic chemotherapy for advanced HER2-positive breast cancer; current …
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer [Phase 1]
This is a Phase 1 trial update for Bavarian Nordic's TAEK-VAC-HerBy Vaccine targeting brachyury and HER2-expressing cancers, including chord…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Probability of OncotypeDx to Reallocate As Low or High Risk of Recurrence Breast Cancer Patients with Uncertain Biology
A completed clinical trial evaluating how Oncotype DX reclassifies recurrence risk in breast cancer patients with uncertain tumor biology.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test [Phase 2]
A Phase 2 study evaluating functional RECAP-guided selection of advanced breast cancer patients for talazoparib treatment; the trial is curr…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer [Phase 2, Phase 3]
A completed Phase 2/3 trial update evaluating adjuvant dynamic marker-adjusted personalized therapy for risk assessment and therapy response…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer [Phase 2]
This is a Phase 2 adjuvant trial evaluating dynamic biomarker–adjusted personalized therapy to optimize risk assessment and therapy response…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer [Phase 3]
A Phase 3 trial comparing Abemaciclib (LY2835219) plus Fulvestrant versus Placebo plus Fulvestrant in previously treated breast cancer has p…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention
This completed single-arm trial evaluated the feasibility and acceptability of a supportive intervention for Black and African American wome…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol. [Phase 2]
This Phase 2 randomized open-label trial within the ADAPT protocol compares preoperative trastuzumab emtansine (T-DM1) with or without stand…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Evaluation of the Functional/Emotional Life Characteristics of Ongoing EAT in BC Patients With Reduced BMD
This is a clinical trial update describing a completed study evaluating functional and emotional quality of life aspects in breast cancer pa…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Meridian Yoga on Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients [NA]
The document reports the completion of a clinical trial evaluating Meridian Yoga for chemotherapy-induced peripheral neuropathy in breast ca…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China [NA]
A completed clinical trial from Fudan University evaluated a financial navigation program intended to reduce financial toxicity among women …
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating correlation between clinical response and pathologic response in patients with early breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response [Phase 3]
This Clinical Trials update describes a multicenter, open-label Phase 3 trial focused on optimizing taxane therapy in elderly patients with …
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol [Phase 2]
Phase 2 trial comparing preoperative trastuzumab and pertuzumab with versus without concurrent taxane chemotherapy in operable HER2-positive…